VERVE Symposium

The official Twitter feed for the VERVE Symposium in conjunction with LINC Australia

[VERVE Symposium @VERVEsymposium]

Join us this year for the 10th anniversary of the https://t.co/xH59NLh6KW !!!
30 Nov - 2 Dec 2023

[VERVE Symposium @VERVEsymposium]

In this fascinating interview, Dr Gary Roubin discusses the origins of interventional cardiology and peripheral vascular interventions, including the influence of his mentor Andreas Gruentzig.

https://t.co/3JGDNcsFYm

[VERVE Symposium @VERVEsymposium]

All VERVE registered delegates will be welcome to attend and we expect ample audience participation.
BEST-CLI Team: Alik Farber, Matthew Menard, Kenneth Rosenfield
Panel: Venita Chandra, Sven Braunlich, Vik Puttaswamy, Marianne Brodmann, Hence Verhagen, Raghu Kolluri, Steven Kum

[VERVE Symposium @VERVEsymposium]

On Thursday the VERVE Symposium will be hosting a special event to discuss the BEST-CLI Trial. It will be held at 7.30am at the ICC, immediately prior to the meeting opening

https://t.co/xH59NLy9MW

@anzsvs @BEST_CLI

[Endovascular Today @EVToday]

Dr. Andrew Holden & Prof. Ramon Varcoe (@RamonVarcoeMD) summarize our issue on SFA treatment that features global experts sharing the latest updates in above-the-knee interventions.
https://t.co/si4sfoMV3E

[VERVE Symposium @VERVEsymposium]

Check out the preliminary program for our 2022 VERVE Symposium and consider joining us in Sydney for the face-2-face meeting

https://t.co/tit4MiJ1Dd

[Eric Secemsky MD MSc @EricSecemskyMD]

1/Today published in @JACCJournals is the 1st global consensus document on IVUS use for lower ext arterial & venous revasc. This document involved >40 international multidisciplinary experts in vascular disease & was led by a 12 person steering committee.

https://t.co/Hzridqneb4

[VERVE Symposium @VERVEsymposium]

The VERVE Symposium is back in 2022 as a fully face-to-face conference once again!!!

Check out our preliminary at https://t.co/tit4MiJ1Dd and mark your calenders for 1-3 December.

We can't wait to see you all again back in Sydney!

[Ramon Varcoe @RamonVarcoeMD]

...when embracing new technology, where the @VEITHsymposium came from and how it's evolved over the last 48yrs.

Fascinating insights into this eminent vascular leader.

@EVToday @VascularNews @hmpVDM @docmrjaff @roblookstein @VIVAPhysicians @VascularSVS @RKTvascular @VascularMD

[Ramon Varcoe @RamonVarcoeMD]

A new study shows an inverse relationship between
operator volume and perioperative S/D rates following CEA and CAS in ANZ. Is it time to consider minimum operator thresholds and networked referral pathways to improve patient outcomes? @anzsvs
https://t.co/iEYfyud2nz

[UChicagoAorta @UChicagoAorta]

Dr. Ross Milner presenting at the 2019 @VERVEsymposium in Sydney, Australia on the topic of TEVAR. Welcome back to the chilly weather, Dr. Milner! #vervesymposium #tevar

[andrew hattam @andrewhattam]

Jim Iliopoulos @VERVEsymposium on how special forces combat care truths are echoed in #vascularsurgery

Evolution in Special Forces Trauma Training & #Trauma Care/Surgery Since Afghanistan & Iraq

[andrew hattam @andrewhattam]

open #vascularsurgery isn’t dead & #bypass is still a solid option for certain patients with critical limb ischemia! excellent talk @VERVEsymposium by @RKTvascular

[Darren Schneider, MD @VascularMD]

Excellent and thoughtful discussion of the role of surgical bypass in #CLTI by ⁦@RKTvascular⁩ ⁦@VERVEsymposium⁩

[Jacqui Robinson @robijacq1]

@VERVEsymposium today. Fabulous presentation by @JillSommerset on pedal artery acceleration time. Such an important adjunctive study for patients. Thanks for the work preparing the remote presentation. Lots of positive feedback. #vascularsonographers #vascularultrasound .

[Darren Schneider, MD @VascularMD]

⁦@garyansel⁩ discussing the impending shortage of #vascular specialists in the US healthcare system ⁦@VERVEsymposium⁩

[Prof Ramesh K Tripathi @RKTvascular]

Brilliant presentation by ⁦@VascularMD⁩ on FEVAR/BEVAR for failed EVARs. ⁦@VERVEsymposium⁩ !

[Prof Ramesh K Tripathi @RKTvascular]

@VERVEsymposium in full flow. Sven Braunlich from Leipzig updating on the Lutonix IDE Clinical Trial. @RamonVarcoeMD @DrShannonThomas

[Intact Vascular, Inc. (A Philips Company) @IntactVascular]

Join us @VERVEsymposium for a presentation by Marianne Brodmann, MD on the above- and below-the-knee TOBA study results for the Tack Endovascular System®. #DissectionsMatter #PAD

Benefit/risk info: https://t.co/9JIPaRYSTx

[VERVE Symposium @VERVEsymposium]

Two days to go to the 2019 VERVE Symposium...Poised to be the best event we've ever run...Don't miss out...Register now!!! https://t.co/xH59NLy9MW